Papatheodoridis, G. V. Et Al. 2017. The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B. HEPATOLOGY , vol.66, no.5 , 1444-1453.

Papatheodoridis, G. V., İDİLMAN, R., Dalekos, G. N., Buti, M., Chi, H., van Boemmel, F., ... Luis Calleja, J.(2017). The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B. HEPATOLOGY , vol.66, no.5, 1444-1453.

Papatheodoridis, ONUR Et Al. "The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B," HEPATOLOGY , vol.66, no.5, 1444-1453, 2017

Papatheodoridis, ONUR Et Al. "The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B." HEPATOLOGY , vol.66, no.5, pp.1444-1453, 2017

Papatheodoridis, G. V. Et Al. (2017) . "The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B." HEPATOLOGY , vol.66, no.5, pp.1444-1453.

@article{article, author={ONUR KESKİN Et Al. }, title={The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B}, journal={HEPATOLOGY}, year=2017, pages={1444-1453} }